RU95120764A -
METHOD FOR ADMINISTRATION OF MEDICINAL SOLUTIONS INTO THE NOSE CAVITY AND Larynxopharynx
- Google Patents
METHOD FOR ADMINISTRATION OF MEDICINAL SOLUTIONS INTO THE NOSE CAVITY AND Larynxopharynx
Info
Publication number
RU95120764A
RU95120764ARU95120764/14ARU95120764ARU95120764ARU 95120764 ARU95120764 ARU 95120764ARU 95120764/14 ARU95120764/14 ARU 95120764/14ARU 95120764 ARU95120764 ARU 95120764ARU 95120764 ARU95120764 ARU 95120764A
Способ введения лекарственных растворов в полость носа и гортаноглотку, отличающийся тем, что лекарственный раствор вводят в нос при вертикальном положении больного и при интенсивном втягивании воздуха носом.The method of introducing drug solutions into the nasal cavity and larynx, characterized in that the drug solution is injected into the nose when the patient is upright and with intensive air retraction by the nose.
RU95120764/14A1995-12-13
METHOD FOR ADMINISTRATION OF MEDICINAL SOLUTIONS INTO THE NOSE CAVITY AND Larynxopharynx
RU95120764A
(en)
METHOD FOR PREPARING PHARMACEUTICAL FORMULATIONS IN WHICH THE FLAVOR OF THE MEDICINE AND DISFORCED BY MEANS OF COATING OF THE MEDICINE WITH A POLYMERIC MEMBRANE
FOERFARANDE FOER FRAMSTAELLNING AV ETT TRANSDERMALT TERAPEUTISKT SYSTEM MED STEGVIS FRIGOERING AV DET AKTIVA AEMNET OCH ANVAENDNING AV DETTA FOER LOKAL ELLER SYSTEMISK ADMINISTRERING AV DET AKTIVA AEMNET.
Use of thymosin alpha 1 in combination with lamivudine or in combination with lamivudine and famciclovir in manufacturing pharmaceutical combination preparations for treating hepatitis b infection.